Abstract: The invention describes a gas permeable fluoropolymer and silicone material used in the construction of cell culture bags.

Abstract: The invention describes a gas permeable fluoropolymer and silicone material used in the construction of cell culture bags.

Abstract: The invention describes a gas permeable fluoropolymer and silicone material used in the construction of cell culture bags.

Abstract: A cell culture container is provided, comprising membrane bound compartments for growing and harvesting monocytes that allows replenishing and removal of feed media without the loss or death of cells.

Abstract: A cell culture container is provided, comprising membrane bound compartments for growing and harvesting monocytes that allows replenishing and removal of feed media without the loss or death of cells.

Abstract: The invention describes a gas permeable fluoropolymer and silicone material used in the construction of cell culture bags.

Abstract: The invention describes a gas permeable fluoropolymer and silicone material used in the construction of cell culture bags.

Abstract: The invention describes a gas permeable fluoropolymer and silicone material used in the construction of cell culture bags.

Abstract: Embodiments of the disclosure include systems and methods for capturing particular biological matter from a sample from an individual. The systems and methods employ an apparatus (such as a container that is a tube or bag) comprising a fluoropolymer coating that is modified to comprise one or more moieties for binding of a desired biological agents when a sample is exposed to the modified fluoropolymer. In particular aspects, the biological matter is a particular type of cell, such as a particular blood or bone marrow cell, and the desired cell is captured by means of an aptamer selected to bind the cell.

Abstract: Embodiments of the disclosure include systems and methods for capturing particular biological matter from a sample from an individual. The systems and methods employ an apparatus (such as a container that is a tube or bag) comprising a fluoropolymer coating that is modified to comprise one or more moieties for binding of a desired biological agents when a sample is exposed to the modified fluoropolymer. In particular aspects, the biological matter is a particular type of cell, such as a particular blood or bone marrow cell, and the desired cell is captured by means of an aptamer selected to bind the cell.

Abstract: A cell culture container is provided, comprising membrane bound compartments for growing and harvesting monocytes that allows replenishing and removal of feed media without the loss or death of cells.

Abstract: A primary package containing a low molecular weight peptide-based thrombin inhibitors which package is sealed with a rubber stopper or plunger containing bromobutyl rubber.

Abstract: A primary package containing a low molecular weight peptide-based thrombin inhibitors which package is sealed with a rubber stopper or plunger containing bromobutyl rubber.

Abstract: There is provided immediate release pharmaceutical formulations comprising, as active ingredient, 4-([3-[7-(3,3-dimethyl-2-oxobutyl)-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl]propyl]amino)benzonitrile, tert-butyl 2-{7-[3-(4-cyanoanilino)propyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethyl-carbamate, tert-butyl 2-{7-[4-(4-cyanophenyl)butyl]-9-oxa-3,7-diaza-bicyclo[3.3.1]non-3-yl}ethylcarbamate or tert-butyl 2-{7-[(2S)-3-(4-cyanophenoxy)-2-hydroxypropyl]-9-oxa-3,7-diazabicyclo[3.3.1]non-3-yl}ethylcarbamate, or a pharmaceutically-acceptable salt of any of these compounds, and a pharmaceutically-aceptable diluent or carrier. There is further provided solid pharmaceutical compositions comprising an above-stated active ingredient, which compositions are suitable for the preparation of immediate release pharmaceutical formulations, and which compositions may be prepared for example by freeze-drying. The formulations and compositions are useful in the prophylaxis and/or treatment of cardiac arrhythmias.

Abstract: A primary package containing a low molecular weight peptide-based thrombin inhibitors which package is sealed with a rubber stopper or plunger containing bromobutyl rubber.

Abstract: A primary package containing a low molecular weight peptide-based thrombin inhibitors which package is sealed with a rubber stopper or plunger containing bromobutyl rubber.

Abstract: A primary package containing a low molecular weight peptide-based thrombin inhibitors which package is sealed with a rubber stopper or plunger containing bromobutyl rubber.

Abstract: A primary package containing a low molecular weight peptide-based thrombin inhibitors which package is sealed with a rubber stopper or plunger containing bromobutyl rubber.